Zinc & thiazide diuretics

Our assessment

Based on FDA data, the overall safety profile for thiazide diuretics is well-established, but there are important risks to monitor. These medications are commonly used for hypertension, and their effects on electrolyte balance require careful oversight. The most critical finding from FDA data is the potential for significant electrolyte disturbances, which can have serious consequences if not managed properly FDA FAERS ↗.

Safety profile

FDA received adverse event reports for thiazide diuretics including electrolyte imbalances such as hypokalemia (low potassium) and hyponatremia (low sodium). Specific side effects reported to the FDA include metabolic disturbances like hyperglycemia and hyperuricemia. Patients should also be aware of reports of dizziness, headache, and gastrointestinal disturbances such as nausea and vomiting FDA FAERS ↗. The number of reports for each specific side effect is not available in the provided data.

How it works

Thiazide diuretics work by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule of the kidney. This action increases the excretion of sodium and water, which reduces blood volume and lowers blood pressure. The effect on electrolyte balance is a key mechanism that also underlies the primary safety concerns FDA FAERS ↗.

Our recommendation

Patients taking thiazide diuretics should have their electrolyte levels, particularly potassium and sodium, monitored regularly by their healthcare provider. Individuals with a history of gout, diabetes, or kidney disease should be especially cautious, as these conditions may be exacerbated. Drug interactions are noted as N/A in the provided data, so no specific interaction information is available. Always consult your prescribing physician before making any changes to your medication regimen FDA FAERS ↗.